CAMBRIDGE, Mass., Nov. 18, 2020 /PRNewswire/ — Particles for Humanity, a biotechnology firm reworking early-stage applied sciences into merchandise for folks in low-resource settings, has obtained a $5 million grant from the Invoice & Melinda Gates Basis. The funding will probably be used to judge a Single Injection (SI) vaccine supply expertise that delivers all of the doses required for full immunization in a single injection. The expertise, revealed in Science, was invented on the Massachusetts Institute of Know-how (MIT), by Drs. Robert Langer and Ana Jaklenec, and made obtainable to the corporate underneath an possibility settlement with MIT.
Many vaccines require a number of doses to realize immunity, which is among the explanation why greater than 19 million youngsters are under-vaccinated, resulting in 1.5 million vaccine-preventable deaths annually. Non-compliance to full vaccination regimens is a extreme public well being danger in an more and more globalized world. Lowering the variety of injections and clinic visits required to realize immunity may decrease obstacles to looking for life-saving well being interventions.
The SI expertise is a platform expertise from which many potential merchandise could be developed. It has the potential to enhance quite a few licensed vaccines towards ailments resembling Human Papilloma Virus (HPV), Hepatitis B, rabies, polio, malaria, and shingles. This platform expertise may additionally play an important position in creating novel vaccines, which can be more likely to require a number of injections, for ailments resembling HIV and COVID-19. The World Well being Group (WHO) estimates that 38 million folks had been dwelling with HIV in 2019, and 50 million folks have been contaminated by COVID-19 in 2020 up to now.
“This pandemic highlights how crucial vaccines are to defending our world neighborhood. A number of injections create a barrier to every particular person’s potential to realize full immunization, in addition to a burden on the well being system to fabricate, bundle, ship, retailer, and administer a number of doses. These issues can change into acute throughout a pandemic when billions of individuals have to be vaccinated shortly,” says Particles for Humanity’s CEO and co-founder, Sherri C. Oberg. “This expertise is a chance to enhance entry to life-saving vaccines for people whereas minimizing the burden on the well being care system.”
“The SI platform expertise can launch any variety of doses – at anyplace from 2 to even over 10 totally different time factors, which may very well be necessary for right now’s and tomorrow’s vaccines that require a number of injections to realize and maintain the specified antibody titres.” says Dr. Robert S. Langer, ScD, the David H. Koch Institute Professor at MIT.
Particles for Humanity will use the funding to show efficacy in animals utilizing rabies as a mannequin vaccine. The corporate’s possibility settlement with MIT gives for analysis of the SI expertise and the choice to barter for an unique world license to all kinds of vaccines for infectious ailments, in addition to a non-exclusive world license to vaccines for SARS-CoV-2 that causes COVID-19.
Particles for Humanity is creating a portfolio of merchandise for enhancing vaccines and decreasing malnutrition, with $14 million in cumulative funding from the Invoice & Melinda Gates Basis. Its rigorous product improvement course of relies on end-user enter and is targeted on financially sustainable product alternatives. For extra info, go to the corporate’s web site www.particlesfh.com.
For media inquiries, please contact: Zoe Thorsland, [email protected]
SOURCE Particles for Humanity